2022
DOI: 10.1186/s12959-022-00428-5
|View full text |Cite
|
Sign up to set email alerts
|

Serum interleukin 1β and sP-selectin as biomarkers of inflammation and thrombosis, could they be predictors of disease severity in COVID 19 Egyptian patients? (a cross-sectional study)

Abstract: Background Thromboembolism was a chief cause of mortality in 70% of patients with COVID-19. Our objective was to see if serum interleukins 1 beta (IL-1β) and soluble platelets selectin (sP-selectin) could serve as novel markers of thromboembolism in COVID-19 patients. Methods This cross sectional study involved 89 COVID-19 patients who were recruited from 1st of February to 1st of May 2021. Clinical and laboratory data were collected, and chest ima… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 24 publications
1
5
0
Order By: Relevance
“…Moreover, it has been previously revealed that the circulating dimerized soluble P‐selectin promotes inflammation and coagulation (Panicker et al., 2017). Additionally, P‐selectin has been reported as one of the biomarkers of COVID‐19 severity (Abd El‐Ghani et al., 2022; Karsli et al., 2021), supporting that our mouse model reflects COVID‐19 pathogenesis. However, our present study has several limitations.…”
Section: Discussionsupporting
confidence: 78%
“…Moreover, it has been previously revealed that the circulating dimerized soluble P‐selectin promotes inflammation and coagulation (Panicker et al., 2017). Additionally, P‐selectin has been reported as one of the biomarkers of COVID‐19 severity (Abd El‐Ghani et al., 2022; Karsli et al., 2021), supporting that our mouse model reflects COVID‐19 pathogenesis. However, our present study has several limitations.…”
Section: Discussionsupporting
confidence: 78%
“…IL-1 maintains thrombosis by increasing the time of clot lysis, upregulation of TF expression, and activation of the endothelium via the IL-1β pathway, also promoting the recruitment of leukocytes [ 81 ]. In one study, in patients with COVID-19-associated thrombotic events, no statistical significance was recorded between serum levels of inflammatory markers (CRP, ferritin), age, and other clinical characteristics, except for IL-1β and soluble P-selectin [ 83 ].…”
Section: Biological Mechanisms For In Situ Pulmonary Immunothrombosismentioning
confidence: 99%
“…P-selectin, another biomarker of endothelial degranulation, blocks the initial attachment and rolling of platelets and leukocytes to inflammatory regions [ 17 ]. In COVID-19 patients, P-selectin could be a biomarker of severe disease and associated venous thrombosis [ 17 , 83 , 119 , 122 , 123 , 124 ]. P-selectin might also be detrimental in COVID-19 as it promotes NETosis through binding to P-selectin glycoprotein ligand-1 (PSGL-1), leading to the development of immunothrombosis and ALI/ARDS [ 51 , 125 ].…”
Section: Biological Mechanisms For In Situ Pulmonary Immunothrombosismentioning
confidence: 99%
See 2 more Smart Citations